Image Guidance Method for Diabetic Foot Surgery
Image Guidance Method for Diabetic Foot Surgery
批准号:
7999884
负责人:
Irving Weinberg
金额:
$38.03万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2011-07-31
关键词:
AbattoirsAcademiaAddressAdoptionAnaerobic BacteriaAnimal ExperimentsAnimal ModelAnimalsAnoxiaBiological AssayBiological ModelsBiomedical EngineeringBiophysicsBloodBurn injuryBusinessesCapitalCaringCellsChildChillsClinicalClinical ProtocolsClinical TrialsCollaborationsCollectionCommerceCommunity HospitalsComputer AssistedComputer softwareCurrent Procedural Terminology CodesCustomData AnalysesDebridementDecubitus ulcerDevelopmentDevicesDiabetes MellitusDiabetic FootDiabetic woundElementsEmployeeEndoscopyEngineeringEnvironmentEquipmentEuropeExcisionEyeFDA approvedFaceFamily suidaeFeedbackFibrosisFluorescenceFundingGamma RaysGoalsGoldGuidelinesHeartHemoglobinHospitalsHumanImageImage-Guided SurgeryImaging DeviceIncentivesIncomeIndiaInflammatoryInpatientsInstitutionIntellectual PropertyInternationalInvestmentsKnowledgeLabelLeadLearningLegal patentLengthLength of StayLettersLicensingLifeLimb SalvageMagicMagnetic Resonance ImagingMarketingMedicalMedical ImagingMedical centerMedicareMethodsMissionMitochondriaModelingNADHNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNecrosisNosocomial InfectionsOperative Surgical ProceduresOpticsOrthopedicsOsteomyelitisPatient NoncompliancePatientsPenetrationPhasePhysiciansPhysicsPhysiologicalPilot ProjectsPodiatryPreparationPriceProceduresProductionProtocols documentationProxyPublicationsPublishingQuality of lifeQuantum DotsRadioactiveReceiver Operating CharacteristicsReportingResearch DesignResectedResidual stateResolutionRespirationSafetySalesSamplingScientistSignal TransductionSiliconSinusSiteSourceSpecimenSpeedStagingStreamStudy SectionSuggestionSurgeonSurgical marginsSystemTailTechnologyTetracyclinesThird-Party PayerTimeTissue ModelTissue ViabilityTissuesTractionUV sensitiveUnited States National Institutes of HealthValidationVendorWeldingWingWorkYeastsagedbaseboneclinical applicationcommercial applicationcostdesigndesign and constructiondetectordiabeticdiabetic patientdigitaldistractionexperiencefluorescence microscopefoothospital bedimprovedinnovationinstrumentationinterestintraoperative imagingkillingsmanufacturing processmillimeterminiaturizemolecular imagingnanomaterialsnew technologynoveloncologyoptical sensoroxidationpathogenpaymentphase 1 studypreferenceprogramspublic health relevanceradiotracerresearch studyresponsesensorsuccesssymposiumtoolwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to improve the care of diabetic patients undergoing surgery for treatment of osteomyelitis. This improvement will be attained by providing immediate intraoperative imaging feedback to podiatrists and surgeons as to whether surgical margins are clear of involvement, and whether remaining tissues are healthy. Often, patients reside in hospital beds while pathological assessment of tissue specimens is pending, adding to overall care costs and exposing patients to potential nosocomial infection. A rapid and reliable method of assessing surgical margins intraoperatively could potentially reduce hospital stays. Providing additional confidence might allow surgeons and podiatrists to be more conservative in their resections, thereby improving patients' quality of life. The commercial market for diabetic osteomyelitis care has been estimated at $10 billion annually, with a similar amount for non- bone wound care. The project takes advantage of recent innovations in miniaturized fluorescence microscopes, and applies lessons learned in oncology imaging, towards the goal of rapid identification of surgical margins for osteomyelitis patients. Follow-on applications for the technology to be developed in this project include decubitus ulcer debridement, and other wound care challenges. Unlike prior imaging approaches that employed exogenous contrast materials (e.g., tetracycline, labeled radiotracers) we propose to use endogenous optically-active markers (e.g., mitochondrial NADH) to rapidly assess tissue viability in this important clinical application. The project is distinguished by a cross-cutting academic-industrial collaboration including experts in medical imaging, wound care, and sensor engineering and physics. Since the original application, and in response to the suggestions of the reviewers, our group has conducted preliminary experiments validating the basic physiological assumptions that the project is based on. The results of these pilot studies are included in the revised application.
PUBLIC HEALTH RELEVANCE: The overall goal of this project is to improve the care of diabetes patients undergoing surgery for treatment of osteomyelitis. This improvement will be attained by providing immediate intraoperative imaging feedback to podiatrists and surgeons as to whether surgical margins are clear of involvement, and whether remaining tissues are healthy. Often, patients reside in hospital beds while pathological assessment of tissue specimens is pending, adding to overall care costs and exposing patients to potential hospital-acquired infections. A rapid and reliable intraoperative method of assessing surgical margins could potentially reduce hospital stays. Providing additional confidence might allow surgeons and podiatrists to be more conservative in their resections, thereby improving patients' quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
-
批准号:9908814
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2019
-
负责人:Irving Weinberg
-
依托单位:
Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
-
批准号:10210039
-
项目类别:
-
资助金额:$69.53万
-
财政年份:2019
-
负责人:Irving Weinberg
-
依托单位:
Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
-
批准号:10247835
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2019
-
负责人:Irving Weinberg
-
依托单位:
Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
-
批准号:10092710
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2019
-
负责人:Irving Weinberg
-
依托单位:
Targeting Deep Brain Tumors with MRI-Insertable Magnetic Gradients and Nanopartic
-
批准号:8524216
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2013
-
负责人:Irving Weinberg
-
依托单位:
Novel MRI Gradient Coil Manufacturing Methods
-
批准号:8312984
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2012
-
负责人:Irving Weinberg
-
依托单位:
High-quality compact portable low-field head MRI with ultra-fast gradients
-
批准号:9328157
-
项目类别:
-
资助金额:$69.74万
-
财政年份:2011
-
负责人:Irving Weinberg
-
依托单位:
Low-Dose MRI-Compatible Molecular Breast Imaging Device
-
批准号:8669785
-
项目类别:
-
资助金额:$76.74万
-
财政年份:2010
-
负责人:Irving Weinberg
-
依托单位:
Low-Dose MRI-Compatible Molecular Breast Imaging Device
-
批准号:8525076
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2010
-
负责人:Irving Weinberg
-
依托单位:
Low-Dose MRI-Compatible Molecular Breast Imaging Device
-
批准号:7800343
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2010
-
负责人:Irving Weinberg
-
依托单位:
Low-Dose MRI-Compatible Molecular Breast Imaging Device
-
批准号:8849388
-
项目类别:
-
资助金额:$46.91万
-
财政年份:2010
-
负责人:Irving Weinberg
-
依托单位:
Fast PET Dosimetry for Proton Therapy
-
批准号:7612997
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:Irving Weinberg
-
依托单位:
Pb-Qdot Direct Gamma Detectors
-
批准号:7613016
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2008
-
负责人:Irving Weinberg
-
依托单位:
Pb-Qdot Direct Gamma Detectors
-
批准号:8124374
-
项目类别:
-
资助金额:$60.68万
-
财政年份:2008
-
负责人:Irving Weinberg
-
依托单位:
Pb-Qdot Direct Gamma Detectors
-
批准号:8291996
-
项目类别:
-
资助金额:$60.51万
-
财政年份:2008
-
负责人:Irving Weinberg
-
依托单位:
Pb-Qdot Direct Gamma Detectors
-
批准号:8495060
-
项目类别:
-
资助金额:$58.94万
-
财政年份:2008
-
负责人:Irving Weinberg
-
依托单位:
Pb-Qdot Direct Gamma Detectors
-
批准号:7695053
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2008
-
负责人:Irving Weinberg
-
依托单位:
Could Dedicated Breast PET Predict Multifocality?
-
批准号:6941824
-
项目类别:
-
资助金额:$64.03万
-
财政年份:2003
-
负责人:Irving Weinberg
-
依托单位:
Would Perioperative PET Imaging Improve Lumpectomy?
-
批准号:6804117
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2003
-
负责人:Irving Weinberg
-
依托单位:
海外基金